🔴 Moleculin Biotech is trading 5.84% down in pre-market with no verified company-specific negative announcement identified

Moleculin Biotech is trading 5.84% down at $0.42 after no verified company-specific negative announcement was identified for August 12, 2026.

• The weakness follows recent volatility surrounding MIRACLE trial data and the recently completed $9.3 million financing, but neither clearly explains the pre-market decline.
• Broader indexes are higher, so market-wide weakness does not appear to be the catalyst.